No single molecular drug target

The term 'No single molecular drug target' is a classification used in pharmacology and drug databases to describe therapeutic agents whose mechanism of action does not involve a specific, identifiable protein, nucleic acid, or other molecular entity (ChEMBL Database, 2024). This category often includes substances like general anesthetics, which may exert their effects through non-specific interactions with the lipid bilayer of cell membranes, or complex mixtures where the clinical outcome is the result of synergistic effects across multiple pathways (StatPearls, 2023). Because these agents lack a discrete binding site, they often exhibit broad physiological effects rather than targeted therapeutic actions. For biotech analysts, this designation highlights a challenge in drug design, as traditional structure-based drug discovery cannot be applied. Instead, the efficacy and safety of such agents are typically evaluated through phenotypic assays and systemic physiological monitoring (NIH, 2022). This classification is also applied to drugs that act through purely physical or chemical properties, such as osmotic laxatives or antacids that neutralize stomach acid (PubMed, 2021). Consequently, drugs in this category are often associated with a higher risk of off-target effects due to their inherent lack of molecular selectivity.

Other names

Non-specific targetUnknown targetNon-molecular targetPhysicochemical mechanism

Non-specific chemical or physical interactions, such as neutralization of gastric acid, osmotic gradient creation, or perturbation of lipid membrane fluidity.